admin – Page 3354 – Get News Story

Infection Control Market worth $69.2 billion | MarketsandMarkets™

“European Infection Control market is expected to be worth USD 21.0 billion in 2029 growing at CAGR of 6.5% during the forecast period.”

The global infection control market, valued at US$49.0 billion in 2023, is forecasted to grow at a robust CAGR of 6.3%, reaching US$51.0 billion in 2024 and an impressive US$69.2 billion by 2029.

Infection Control Market in terms of revenue was estimated to be worth $51.0 billion in 2024 and is poised to reach $69.2 billion by 2029, growing at a CAGR of 6.3% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The infection control market has grown as a result of many drivers, including rising healthcare-associated infections (HAIs) and antibiotic resistance drive demand for innovative solutions. Aging populations with weakened immune systems, coupled with an increase in complex surgeries and minimally invasive procedures, create fertile ground for infection risks.

Technological advancements like automation, artificial intelligence in disinfection robots, and nanotechnology-based antimicrobial surfaces offer promising solutions. Sustainability is gaining traction, with eco-friendly disinfectants and reusable personal protective equipment (PPE) gaining favor. Furthermore, growing awareness of occupational hazards in healthcare settings fuels demand for safer equipment and training. This dynamic market is poised for continued growth, driven by the relentless pursuit of preventing infections and safeguarding public health.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1084

The market growth of infection control is significantly boosted by advancements in sterilization equipment technology. These innovations enhance efficiency and efficacy in sterilization processes, meeting rising demands for infection prevention across various industries. As technology evolves, businesses can access more sophisticated solutions, driving market expansion and improving overall infection control standards.

Furthermore, the infection control industry is growing as the number of surgical operations increases. With surgical interventions becoming more common, there’s a heightened need for stringent infection prevention measures. This surge in surgical activities drives the demand for infection control products and services. As healthcare facilities strive to maintain sterile environments, the market expands to meet the increasing requirements, fostering business opportunities within the industry.

The Infection Control Market is further segmented based on product & service, end user and region.

The cleaning and disinfection product segment holds the largest market share during the forecast period.

Cleaning and disinfection products hold the largest market share in the infection control market. This dominance stems from their pivotal role in preventing the spread of infections across various sectors. As businesses and healthcare facilities prioritize cleanliness and hygiene, the demand for effective cleaning and disinfection solutions continues to surge. These products play a crucial role in maintaining sanitized environments, especially in the face of heightened awareness about infectious diseases. With stringent regulations and standards driving the need for robust infection control measures, cleaning and disinfection products remain indispensable, commanding a significant portion of the market.

The Endoscope reprocessing product segment is expected to grow at the highest rate during the forecast period.

Endoscope reprocessing products have recorded the highest Compound Annual Growth Rate (CAGR) in the infection control market. This remarkable growth can be attributed to the increasing utilization of endoscopic procedures in medical diagnostics and treatments. As endoscopes are extensively used across healthcare facilities, the demand for effective reprocessing solutions escalates to ensure the safety and reliability of these devices. With a growing emphasis on infection prevention and patient safety, healthcare providers are investing more in advanced endoscope reprocessing products to meet stringent regulatory requirements and mitigate the risk of Healthcare-Associated Infections (HAIs). Consequently, manufacturers in the infection control market are focusing on innovating and enhancing their endoscope reprocessing product lines.

The remarkable rise underscores the critical role these products play in ensuring patient safety and infection prevention. With the increasing adoption of endoscopic procedures in medical diagnosis and treatment, there’s a parallel surge in demand for reliable and efficient reprocessing solutions. Manufacturers are responding to this growing demand by continually innovating and improving their endoscope reprocessing product offerings, thereby driving further market growth.

In the end-user segment, hospitals and clinics hold the largest market share in the Infection Control Market.

In 2023, the hospitals & clinics segment dominated the infection control market. The infection control market for hospitals and clinics is booming, fueled by several key factors and trends. Firstly, the rising prevalence of hospital-acquired infections (HAIs) and antibiotic-resistant bacteria creates a constant need for stricter hygiene protocols and advanced technology. Secondly, an aging population with weakened immune systems increases susceptibility to infections, demanding more robust prevention measures. Additionally, the growing number of surgical procedures and minimally invasive surgeries necessitates meticulous sterilization practices.

Furthermore, public awareness of pandemics like COVID-19 has heightened focus on sanitation and personal protective equipment (PPE), driving demand for these products. Technological advancements play a crucial role, with innovations like ultraviolet disinfection systems, automated hand hygiene dispensers, and robotic cleaners gaining traction. Looking ahead, the market is expected to see increased adoption of single-use medical devices, outsourcing of sterilization services, and a focus on sustainable infection control solutions. Overall, the convergence of these factors positions the infection control market for hospitals and clinics for continued significant growth in the coming years.

North America will continue to dominate the Infection Control Market in 2029.

On the basis of region, the Infection Control Market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa and GCC countries. Firstly, North America’s robust healthcare infrastructure and advanced medical facilities drive significant demand for infection control products and services. Additionally, stringent regulatory standards and heightened awareness of healthcare-associated infections (HAIs) propel the adoption of infection prevention measures. Moreover, the region’s strong emphasis on research and development fosters innovation in infection control technologies, further solidifying North America’s position as a leader in the global infection control market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1084

Infection Control Market Dynamics:

Drivers:

Growing number of surgeries

Restraints:

High cost associated with endoscopy reprocessing coupled with the limited reimbursements in developing nations

Opportunities:

Growing utilization of E-beam sterilization

Challenge:

Sterilization of Advanced Medical Devices

Key Market Players of Infection Control Industry:

The global Infection Control Market is consolidated in nature, with the top players, namely, STERIS plc. (US), Getinge AB (Sweden), Ecolab, Inc. (US), 3M Company (US), Advanced Sterilization Products (US), Sotera Health LLC (US), MMM Group (Germany), MATACHANA GROUP (Spain), Belimed AG (Switzerland), Metrex Research LLC (US), Reckitt Benckiser (UK), Pal International (UK), Olympus Corporation (Japan). Melag Medizintechnik GmbH & Co. KG (Germany), Miele Group (Germany), Systec GmbH & Co. KG(Germany), Contec, Inc. (US), Continental Equipment Company (US), MEDALKAN (Greece), C.R.M. S.R.L. Medical Equipment (Italy), and Spire Integrated Solutions (US) accounting for a larger share of the market.

A breakdown of the primary participants (supply-side) for the infection control market referred to for this report is provided below:

By Company Type: Tier 1: 55%, Tier 2: 30%, and Tier 3: 15%
By Designation: C-level: 28%, Director-level: 43%, and Others: 39%
By Region: North America: 35%, Europe: 20%, Asia Pacific: 30%, Latin America: 7%; Middle East & Africa: 5%, and GCC Countries: 3%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=1084

Infection Control Market – Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall infection control market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (Rising prevalence of healthcare-associated infections (HAIs), Growing number of surgeries, Advancement in reprocessing technologies, Rising emphasis on the sterilization and disinfection of food, Advancements in sterilization equipment technology, Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals), restraints (Growing concerns about the safety of reprocessed instruments, Consequences associated with the use of chemical disinfectants, High cost associated with endoscopy reprocessing coupled with the limited reimbursements in developing nations, ), opportunities (The increasing prevalence of medical devices and pharmaceutical companies in developing nations, Growing utilization of E-beam sterilization, Reintegration of ethylene oxide sterilization) and challenges (Sterilization of Advanced Medical Devices, Alternative methods for surface disinfection, Increasing adoption of single-use medical nonwovens and devices).
Market Penetration: Comprehensive information on product portfolios offered by the top players in the global infection control market. The report analyzes this market by product & service, end user, and region.
Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global infection control market.
Market Development: Comprehensive information on the lucrative emerging markets by product & service, end user, and region.
Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global infection control market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global infection control market.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/infection-control-market-1084.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Infection Control Market worth $69.2 billion | MarketsandMarkets™

Pharmaceutical Drug Delivery Market to Hit USD 2,546 Billion by 2029 | MarketsandMarkets™

“North America dominates the pharmaceutical drug delivery market. This market is projected to reach USD 1,215.4 billion by 2029, at a CAGR of 5.0% during the forecast period.”

The global pharmaceutical drug delivery market, valued at US$1,831.1 billion in 2023, is forecasted to grow at a robust CAGR of 5.5%, reaching US$1,949.4 billion in 2024 and an impressive US$2,546.0 billion by 2029.

The global pharmaceutical drug delivery market is set to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029, with a CAGR of 5.5%. This growth is driven by increasing chronic disease prevalence, new product launches, enhanced pharmaceutical R&D investments, and government initiatives for affordable drug delivery. The market also benefits from technological advancements, patient preference for home care, and supportive reimbursement policies. However, challenges include the risk of needlestick injuries from injectables and government pricing pressures. Key players in the market include Johnson & Johnson, Novartis, F. Hoffmann-La Roche, Pfizer, and others. Injectable drug delivery is expected to dominate the market, driven by advancements in self-administration technologies and the increasing prevalence of chronic diseases. North America is predicted to hold the largest market share due to favorable reimbursement options and high healthcare expenditure. Recent developments include acquisitions by major companies like Johnson & Johnson, AbbVie, and Pfizer to enhance their drug delivery capabilities.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085

Injectable Drug Delivery Sector Leading the Market

Injectable drug delivery holds the largest market share among administration routes, primarily due to its effectiveness in managing chronic diseases. Injectables offer advantages over oral medications by improving patient adherence and reducing dosing frequency. Advances in injectable technologies, aimed at minimizing needle pain and complications, are further fueling growth in this segment.

Hospitals to Experience Rapid Market Expansion

The pharmaceutical drug delivery market is segmented by facility of use, including hospitals, ambulatory surgical centers, diagnostic centers, home care settings, and other facilities. Hospitals are projected to see the most substantial growth due to high patient traffic, increased need for various medications and delivery devices, a rise in surgeries, and a growing prevalence of chronic diseases, which are driving up hospital admissions and, consequently, the demand for drug delivery solutions.

Asia Pacific Region Poised for Significant Growth

The pharmaceutical drug delivery market is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is expected to register the highest growth rate in the coming years, driven by the presence of leading pharmaceutical companies, a growing patient population with chronic conditions, increased healthcare spending, and government efforts to enhance access to pharmaceutical treatments in the region.

Major Market Players and Their Strategies

Prominent players in the pharmaceutical drug delivery market include Johnson & Johnson Services, Inc. (US), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Sanofi (France), Bayer AG (Germany), Amgen, Inc. (US), AbbVie Inc. (US), Genmab A/S (Denmark), Gilead Sciences, Inc. (US), Boehringer Ingelheim International GmbH (Germany), and AstraZeneca (UK).

Johnson & Johnson Services, Inc. Focuses on Innovation

Johnson & Johnson Services, Inc., a leading player in the pharmaceutical drug delivery market, offers a broad range of products across major therapeutic areas. The company emphasizes product innovation and R&D, with an annual R&D expenditure of approximately USD 15 million, accounting for 17.7% of its total revenue. Johnson & Johnson has a strong presence in North America, Europe, Asia Pacific, and Africa. To ensure continued growth, the company pursues partnerships, agreements, and mergers and acquisitions to expand its product portfolio and regional reach.

Novartis AG: A Key Market Leader

Novartis AG stands out in the pharmaceutical drug delivery market due to its extensive global presence and strong brand recognition. The company offers a comprehensive portfolio in therapeutic areas such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology. Novartis focuses on high-growth fields and prioritizes resource allocation to these areas. The company strengthens its business through strategic partnerships, collaborations, and agreements to enhance its operations and market position.

For more information, Inquire Now!

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pharmaceutical Drug Delivery Market to Hit USD 2,546 Billion by 2029 | MarketsandMarkets™

Microcars Market Size worth USD 49.00 billion by 2032

“Microcars Market”

Microcars Market by Category (Kei Cars, A00, Neighborhood Electric Vehicles, Quadricycles), Power Output (<5, 5-25, 26-40, >40 kW), End-use Application, Kei Cars and Quadricycles (Propulsion and Classification), and Region – Global Forecast to 2032

The microcars market is projected to grow from USD 36.75 billion in 2025 to USD 49.00 billion by 2032 at a CAGR of 4.2%.

The microcars market is expanding in Asia due to increased urbanization; population shifts from rural to urban areas, and the ongoing developments in electric & hybrid technology. Technological advancements in microcars, such as connected car features and integration of width adjustment technology, would increase the demand for advanced microcars.

The personal end-use application is estimated to account for the largest share of the microcars market in 2025.

According to MarketsandMarkets, at present, around 94% of microcars are being used for personal commutes. One of the major drivers for this growth is rising urbanization, which has resulted in increased city traffic and the lack of efficient public transportation to handle increased passenger volume. Microcars are short and compact, offer better options for short-distance commutes, and can be parked in a compact space. Most of the microcars used in China and Japan are used for short-distance travel and urban commuting; they serve as second vehicles for family members, especially in urban areas. Further, in Europe and the US, NEVs and quadricycles are more popular for personal use, mainly for urban commuting in cities where limited parking is available. Also, in Europe, license-accessible options for drivers above 16 years are driving the adoption of microcars among the younger population. The penetration of electric microcars is growing in Europe, Asia Pacific, and North America.

Electric microcars are sustainable and offer affordability to customers who are looking for economical transport alternatives. As these cars are primarily meant for city transit, they can be designed as pure battery electric cars, which will have negligible emissions and range issues. Currently, most battery electric microcars have a driving range from 60 km to 180 km on a full charge, which is sufficient for city transit. Thus, with growing electric microcar adoption and the rising popularity of microcars in urban areas for short-distance commutes, the market is expected to expand.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117059235

Quadricycles are projected to register the fastest growth in the microcars market by category during the forecast period.

Quadricycles include the L6 and L7 versions, which represent light and heavy quadricycles, respectively, in Europe and India. The light quadricycles (L6) are under 4 kW power output, whereas heavy quadricycles (L7) have power output in the range of 5-15 KW available in both ICE and electric propulsion. The quadricycles market in India is still low compared to other countries, as these vehicles are mostly used as taxis; the sales of these cars are mostly seen in the southern part of India. In Europe, L7 quadricycles are preferred due to their high power output compared to L6 and the smaller cost difference between L6 and L7. Several OEMs, such as Aixam and Ligier Group, offer ICE and Electric L7 quadricycles in the European market. Additionally, the Spanish government has approved the B1 license from January 2024 for customers who are 16 years old and who are allowed to drive an electric L7 quadricycle.

In India, only the Bajaj Qute is available under the L7 quadricycle category. However, several models are expected to be launched by OEMs like PMV Electric and Wings EV in the Indian market.

Asia is estimated to be the largest microcar market.

China, India, Japan, and South Korea have been considered for the microcars market analysis in Asia. The region leads the global microcars market due to the high demand for Chinese A00 vehicles and Japanese Kei cars. The lower initial and operating costs are also the key drivers for these vehicles in the region. China and Japan together account for more than 99% of the total regional market, with China having a share of 35.8% and Japan having a share of 64.1% in terms of value.

The Chinese microcars market has experienced growth in terms of developments in the charging infrastructure in the country. The A00 category vehicles have been fully electric since 2022. The growth of Kei cars is influenced by the developments in hybrid technology by Honda Motor Co., Ltd, Suzuki Motor Corporation, Toyota Motor Corporation, and Mitsubishi Motors Co., Ltd.

Key Market Players

Major microcar manufacturers in the region are SAIC-GM-Wuling (China), BYD Auto Co., Ltd. (China), Suzuki Motor Corporation (Japan), Honda Motor Corporation (Japan), Daihatsu Motor Co., Ltd. (Japan), Nissan Motor Co. Ltd. (Japan) and Mitsubishi Motors Co., Ltd. (Japan).

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=117059235

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microcars Market Size worth USD 49.00 billion by 2032

Perforating Gun Market worth $1.48 Billion by 2030

The global perforating gun market is expected to grow from estimated USD 1.19 billion in 2025 to USD 1.48 billion by 2030, at a CAGR of 4.5% during the forecast period.

The global Perforating Gun Market is anticipated to grow from estimated USD 1.19 billion in 2025 to USD 1.48 billion by 2030, at a CAGR of 4.5% during the forecast period. The major factors driving the growth of the perforating gun market are rising exploration and production of unconventional oil & gas resources, especially in the north american region. additionally, long-term factors such as increasing upstream activities and the presence of experienced oilfield service companies drive growth in the perforating gun market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135152126

Wireline Conveyed Casing Segment, by Gun Type

The perforating gun market is significantly driven by the wireline conveyed casing gun system, which offers faster and more precise perforation with reduced operational costs. This system provides a highly efficient solution, making it an attractive choice for oil and gas operators looking to optimize well productivity while minimizing expenses. As the demand for more cost-effective and advanced perforating technologies rises, the wireline-conveyed casing gun system is expected to continue dominating the market and supporting its overall growth.

3,001–8,000 ft, by Depth

The growth of wells ranging in depth from 3,001–8,000 ft. In the perforating gun market has been driven by lower operational costs and faster return on investment. These wells require shorter rig time, simpler equipment, and reduced logistics, making them attractive for cost-sensitive operations. Key advantages supporting this trend include quicker project turnaround and the ability for operators to generate revenue sooner, benefiting small and independent companies aiming to minimize risk and improve cash flow efficiency. Thus, market growth driven by the combined support of cost efficiency and accelerated revenue generation from faster project completion propels this segment’s demand.

Regional Analysis

Countries in north america have significantly increased e&p activities focused on shale and tight oil reserves, particularly in the us and canada. Advanced drilling technologies have been employed to efficiently access and produce from unconventional oil reservoirs to support this growth. Key developments driving the perforating gun market in the region are high shale and tight oil production, a strong oilfield service sector, and a favorable investment environment. As a result, the demand for advanced perforating systems continues to rise, cementing north america’s position as the market leader.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=135152126

Key Players

Some of the major players in the Perforating Gun Market are SLB (US), Weatherford (US), Baker Hughes Company (US), Halliburton (US), and NOV (US). The major strategies adopted by these players include acquisitions, sales contracts, agreements, partnerships, and collaborations.

SLB (US)

SLB (US) provides products, services, technologies, information solutions, and integrated project management solutions to the oil & gas market. It is involved in reservoir characterization, drilling, production, and processing, and the research and engineering, manufacturing, operations, maintenance, and resource planning constitute its core business activities. It carries on its operations through its four business segments, i.e., Digital & Integration, Reservoir Performance, Well Construction, and Production Systems. It provides perforating guns under the Reservoir Performance segment, which contributed to a 19.4% share of the total revenue in 2024. The Reservoir Performance business unit provides wireline services (wireline logging and perforating), formation and fluid characterization testing services, and stimulation services, including pressure pumping, well stimulation, reservoir monitoring, and downhole data acquisition. The organization is focused on strengthening this base in the market. For instance, in April 2024, SLB announced the acquisition of ChampionX (US), an artificial lift specialist. With this initiative, SLB expanded its product line in the upstream industry’s production sector, which, unlike drilling and completions, comprises most of a well’s life.

Weatherford (US)

Weatherford (US) is among the leading multinational oilfield service companies that deliver technologies, solutions, and services for upstream activities in the oil & gas industry. It offers equipment and services for both onshore and offshore operations. The company operates its business through four segments: Drilling & Evaluation, Well construction and completions, Production and Intervention, and Others. Weatherford offers perforating guns through the Drilling & Evaluation segment. The firm focuses on adopting various strategies to expand its reach in the market. For instance, in September 2024, Weatherford acquired Datagration Solutions Inc. (US), a pioneer in machine learning, analytics, and unified data integration. Through the acquisition, Weatherford now offers one of the most advanced and modern digital solutions for production and asset optimization in the oil & gas sector.

For more information, Inquire Now!

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets™ INC.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA: +1-888-600-6441

Email: newsletter@marketsandmarkets.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Perforating Gun Market worth $1.48 Billion by 2030

Skyrocket Marketers Unveils Specialized Web Design and SEO Services for Fintech Firms in Nicosia, Cyprus

“Skyrocket Marketers Agency”

Cutting-Edge Digital Services Now Accessible for Fintech Brands Aiming to Boost Their Online Reach

Skyrocket Marketers – a rising force in the digital marketing scene from Nicosia, Cyprus – has officially launched a focused suite of services, offering expert web design and SEO solutions crafted specifically for fintech businesses. This latest initiative seeks to support the growth of Cyprus-based fintech firms by enhancing their online visibility through smart, data-driven digital strategies.

Founded and led by seasoned digital entrepreneur Andreas Ioannou, Skyrocket Marketers is built on a foundation of proven success. Ioannou is the visionary behind ventures like Everneed AI and GamesD, which together boast over 100,000 global followers. A thought leader in digital innovation, he shares insights through his popular AI Growth Hub newsletter, the marketing guide Entrepreneur Makeover, and his podcast “Smart But Lazy,” which explores trends in business and tech.

With a keen understanding of the unique needs of fintech companies, Skyrocket Marketers adopts a highly tailored approach, avoiding one-size-fits-all tactics. Every service is backed by rigorous testing and continuous refinement to ensure campaigns deliver meaningful results.

The agency’s core offerings include custom web design services that help fintech brands build sleek, user-centric websites optimized for both performance and search engine visibility. Its SEO services are engineered to drive organic traffic, strengthen brand authority, and deliver trackable returns on investment.

In addition to SEO Cyprus and web development, Skyrocket Marketers also delivers comprehensive digital marketing support. This includes affiliate marketing, content creation powered by SearchGTP, strategic branding, social media management, and press release outreach—all aimed at giving clients a robust online presence and long-term market edge.

What sets the agency apart is its unwavering commitment to transparency and results. Clients receive frequent updates and detailed performance reports, blending global digital best practices with deep local market insights.

To explore Skyrocket Marketers’ fintech-focused digital solutions, visit: focused digital solutions, visit: https://www.skyrocketmarketers.com

About Skyrocket Marketers

Skyrocket Marketers is a Nicosia based digital agency dedicated to providing customized SEO and web design services to fintech companies and other forward-thinking businesses in Cyprus.

Media Contact
Company Name: EVERNEED AI LTD
Contact Person: Andreas Ioannou
Email: Send Email
City: Nicosia
Country: Cyprus
Website: https://www.skyrocketmarketers.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Skyrocket Marketers Unveils Specialized Web Design and SEO Services for Fintech Firms in Nicosia, Cyprus

Advanced Renal Cell Carcinoma Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Pfizer, AbbVie, Bristol-Myers Squibb, Abbott, Takeda, Amgen, Novartis, AVEO Pharma, Calithera

The Key Advanced Renal Cell Carcinoma Companies in the market include – Dana-Farber Cancer Institute, Huabo Biopharm Co., Ltd., Beijing Scitech-Mq Pharmaceuticals, Oxford BioMedica, Hutchison Medipharma Limited, Takeda, Amgen, Novartis, AVEO Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, SCRI Development Innovations, LLC, Astellas Pharma Inc, and others.

DelveInsight’s “Advanced Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as well as the Antibody Drug Conjugates market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Advanced Renal Cell Carcinoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Advanced Renal Cell Carcinoma Market Forecast

Some of the key facts of the Advanced Renal Cell Carcinoma Market Report:

The Advanced Renal Cell Carcinoma market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
In February 2025, Updated results from a phase 1 study (NCT05122546) presented at the 2025 Genitourinary Cancers Symposium revealed that the combination of CBM588 with cabozantinib (Cabometyx) and nivolumab (Opdivo) enhanced progression-free survival (PFS) and objective response rate (ORR) in patients with metastatic renal cell carcinoma (mRCC), though it did not result in a significant rise in Bifidobacterium spp. levels.
In December 2024, Adicet Bio, Inc. (Nasdaq: ACET), a clinical-stage biotech company focused on developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases, has announced that the first patient has been dosed in its Phase 1 clinical trial investigating ADI-270 in individuals with metastatic or advanced clear cell renal cell carcinoma (ccRCC)
In October 2024, Arcus Biosciences revealed a clinical trial collaboration with AstraZeneca to evaluate the combined use of casdatifan (AB521) and volrustomig in treating patients with clear cell renal cell carcinoma (ccRCC). Casdatifan is Arcus’ experimental HIF-2α inhibitor, while volrustomig is AstraZeneca’s investigational bispecific antibody targeting PD-1 and CTLA-4. Under the terms of the agreement, AstraZeneca will be responsible for sponsoring and conducting the trial.
The Canadian Medical Association Journal (CMAJ) of 2024 states that the occurrence of RCC rises as individuals get older, typically diagnosed around the age of 75 globally. Additionally, males are twice as likely as females to develop this condition.
As per the Canadian Medical Association Journal (CMAJ) in 2024, the general survival expectancy for metastatic RCC is roughly 4 years. Nevertheless, this duration may fluctuate based on variables like the patient’s age, performance level, and any accompanying health conditions.
Key Advanced Renal Cell Carcinoma Companies: Dana-Farber Cancer Institute, Huabo Biopharm Co., Ltd., Beijing Scitech-Mq Pharmaceuticals, Oxford BioMedica, Hutchison Medipharma Limited, Takeda, Amgen, Novartis, AVEO Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, SCRI Development Innovations, LLC, Astellas Pharma Inc, and others
Key Advanced Renal Cell Carcinoma Therapies: Bevacizumab, HB0025, ST-1898 tablets, Trovax, fruquintinib+sintilimab, Cabozantinib, AMG 102, Pazopanib, tivozanib (AV-951), Belzutifan, Temsirolimus (CCI-779), CB-839, ABT-869, Nivolumab, ABT-510/Thrombospondin-1 mimetic, bevacizumab, CP-461, and others
The Advanced Renal Cell Carcinoma epidemiology based on gender analyzed that Males are slightly more affected in the case of Advanced Renal Cell Carcinoma
The Advanced Renal Cell Carcinoma market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Advanced Renal Cell Carcinoma pipeline products will significantly revolutionize the Advanced Renal Cell Carcinoma market dynamics.

Advanced Renal Cell Carcinoma Overview

Advanced Renal Cell Carcinoma (RCC), also known as advanced kidney cancer, refers to cancer that has spread beyond the kidney and nearby lymph nodes to other parts of the body. Renal cell carcinoma originates in the cells of the kidney’s tubules, which are tiny tubes that filter blood and remove waste products to form urine.

Get a Free sample for the Advanced Renal Cell Carcinoma Market Report:

https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market

Advanced Renal Cell Carcinoma Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Advanced Renal Cell Carcinoma Epidemiology Segmentation:

The Advanced Renal Cell Carcinoma market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:

Total Prevalence of Advanced Renal Cell Carcinoma
Prevalent Cases of Advanced Renal Cell Carcinoma by severity
Gender-specific Prevalence of Advanced Renal Cell Carcinoma
Diagnosed Cases of Episodic and Chronic Advanced Renal Cell Carcinoma

Download the report to understand which factors are driving Advanced Renal Cell Carcinoma epidemiology trends @ Advanced Renal Cell Carcinoma Epidemiology Forecast

Advanced Renal Cell Carcinoma Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Advanced Renal Cell Carcinoma market or expected to get launched during the study period. The analysis covers Advanced Renal Cell Carcinoma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Advanced Renal Cell Carcinoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Advanced Renal Cell Carcinoma Therapies and Key Companies

Bevacizumab: Dana-Farber Cancer Institute
HB0025: Huabo Biopharm Co., Ltd.
ST-1898 tablets: Beijing Scitech-Mq Pharmaceuticals
Trovax: Oxford BioMedica
fruquintinib+sintilimab: Hutchison Medipharma Limited
Cabozantinib: Takeda
AMG 102: Amgen
Pazopanib: Novartis
tivozanib (AV-951): AVEO Pharmaceuticals, Inc.
Belzutifan: Merck Sharp & Dohme LLC
Temsirolimus (CCI-779): Pfizer
CB-839: Calithera Biosciences, Inc
ABT-869: AbbVie
Nivolumab: Bristol-Myers Squibb
ABT-510/Thrombospondin-1 mimetic: Abbott
bevacizumab: SCRI Development Innovations, LLC
CP-461: Astellas Pharma Inc

Discover more about therapies set to grab major Advanced Renal Cell Carcinoma market share @ Advanced Renal Cell Carcinoma Treatment Landscape

Advanced Renal Cell Carcinoma Market Strengths

The incidence of RCC has increased in recent years leading to more focus by pharmaceutical firms.
Antiangiogenics in association with targeted immunotherapy is overcoming resistance emphasizing the role of the tumor microenvironment (TME) and this strategy is currently an option in first line treatment.

Advanced Renal Cell Carcinoma Market Opportunities

There are ongoing trials addressing unanswered questions, such as (CAR) T-cell therapy.

Scope of the Advanced Renal Cell Carcinoma Market Report

Study Period: 2020–2034
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Advanced Renal Cell Carcinoma Companies: Dana-Farber Cancer Institute, Huabo Biopharm Co., Ltd., Beijing Scitech-Mq Pharmaceuticals, Oxford BioMedica, Hutchison Medipharma Limited, Takeda, Amgen, Novartis, AVEO Pharmaceuticals, Inc., Merck Sharp & Dohme LLC, Pfizer, Calithera Biosciences, Inc, AbbVie, Bristol-Myers Squibb, Abbott, SCRI Development Innovations, LLC, Astellas Pharma Inc, and others
Key Advanced Renal Cell Carcinoma Therapies: Bevacizumab, HB0025, ST-1898 tablets, Trovax, fruquintinib+sintilimab, Cabozantinib, AMG 102, Pazopanib, tivozanib (AV-951), Belzutifan, Temsirolimus (CCI-779), CB-839, ABT-869, Nivolumab, ABT-510/Thrombospondin-1 mimetic, bevacizumab, CP-461, and others
Advanced Renal Cell Carcinoma Therapeutic Assessment: Advanced Renal Cell Carcinoma current marketed and Advanced Renal Cell Carcinoma emerging therapies
Advanced Renal Cell Carcinoma Market Dynamics: Advanced Renal Cell Carcinoma market drivers and Advanced Renal Cell Carcinoma market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

Table of Contents

1. Advanced Renal Cell Carcinoma Market Report Introduction

2. Executive Summary for Advanced Renal Cell Carcinoma

3. SWOT analysis of Advanced Renal Cell Carcinoma

4. Advanced Renal Cell Carcinoma Patient Share (%) Overview at a Glance

5. Advanced Renal Cell Carcinoma Market Overview at a Glance

6. Advanced Renal Cell Carcinoma Disease Background and Overview

7. Advanced Renal Cell Carcinoma Epidemiology and Patient Population

8. Country-Specific Patient Population of Advanced Renal Cell Carcinoma

9. Advanced Renal Cell Carcinoma Current Treatment and Medical Practices

10. Advanced Renal Cell Carcinoma Unmet Needs

11. Advanced Renal Cell Carcinoma Emerging Therapies

12. Advanced Renal Cell Carcinoma Market Outlook

13. Country-Wise Advanced Renal Cell Carcinoma Market Analysis (2020–2034)

14. Advanced Renal Cell Carcinoma Market Access and Reimbursement of Therapies

15. Advanced Renal Cell Carcinoma Market Drivers

16. Advanced Renal Cell Carcinoma Market Barriers

17. Advanced Renal Cell Carcinoma Appendix

18. Advanced Renal Cell Carcinoma Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Advanced Renal Cell Carcinoma Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Pfizer, AbbVie, Bristol-Myers Squibb, Abbott, Takeda, Amgen, Novartis, AVEO Pharma, Calithera

Garrett Peck Featured in New Professional Spotlight Article Highlighting Career, Community, and Balanced Living

Garrett Peck, a seasoned supply chain professional and respected community member in Plainfield, Illinois, is the subject of a newly published professional spotlight article. The feature offers an in-depth look at Peck’s career journey, personal values, and thoughtful approach to work-life balance, health, and service.

The article presents a semi-biographical narrative written in an accessible, reflective tone. Through a series of insights and direct quotes, readers learn about Peck’s early life in Pennsylvania, his professional development in logistics, and his deep commitment to family and community engagement.

“I’m not here to preach or pretend I have it all figured out,” Peck shares in the article. “I’m here to have conversations that matter.”

The spotlight explores how Peck integrates fitness, mentorship, and service into a busy life, aiming to show how steady, intentional choices can lead to personal and professional fulfillment.

The article also highlights Garrett’s recent efforts to reach a broader audience through his personal website, where he shares practical advice, reflections, and encouragement for professionals navigating the demands of career, family, and self-growth. His story serves as a grounded and relatable example of purposeful living in today’s fast-paced world.

In addition to his professional accomplishments, the article discusses Garrett’s dedication to local community projects, including volunteering at food banks, supporting local schools, and playing an active role in the Plainfield Chamber of Commerce. His commitment to service is a testament to his belief that leadership is not just about career achievements but also about contributing to the well-being of others. His story encourages readers to find balance, prioritize community, and lead with integrity in both their personal and professional lives.

The full article is now available online at the website here.

Media Contact
Contact Person: Garrett Peck
Email: Send Email
City: Plainfield
State: Illinois
Country: United States
Website: garrettpeckillinois.com

MaryMariiARt Children’s Printable Activities Come to Life with AR

These beautifully made activity pages for kids feature QR codes that give characters a life of their own

MaryMariiARt blends classic childhood coloring pages with augmented reality technology to yield a fun experience for children of all ages. Kids can complete adorable, carefully created activities and scan the affixed QR codes with the help of a grown up to bring their characters to life.

Regarding her inspiration for the augmented reality children’s activity pages, creator Mari said, “As a mother of three kids, I know how much kids like to play games on their devices, so I thought this would be great alternative, with mix of no screen time and also could see their page come alive on the device.”

Although leading pediatric experts recommend that children spend no more than two hours per day on screens, statistics show that many young children are spending an average of six hours per day on their devices. Mary set out to change these numbers with fun, educational, and entertaining children’s activities that featured a tech component.

MaryMariiARt’s printable kids’ coloring pages include mazes, coloring pages, and dot-to-dot activities designed to help children build focus, fine motor skills, and early learning foundations while having fun. Each page features a QR code that, when scanned, offers screen-free play sparking curiosity, supporting brain development, and bringing learning to life. The characters come to life on the paper with the help of augmented reality adding a new layer of excitement to each activity.

MaryMariiARt’s pages are available exclusively on Etsy, where there are several pages to choose from. One recent shopper said, “Such a fun surprise! Totally recommend if you’re looking for something creative and screen-smart!

Mary says she is keeping parents and educators in mind as she adds new pages to her inventory. “Whether it’s a rainy day or a homeschool activity, I hope these pages bring as much joy to your home as they do mine,” said Mary.

Learn more now by visiting https://www.etsy.com/shop/marymariiart.

ABOUT MARYMARIIART

MaryMariiARt offers printable activity pages for kids with scannable QR codes to bring characters to life in AR.

Media Contact
Company Name: MaryMariiARt
Contact Person: Mari
Email: Send Email
Country: United States
Website: https://www.etsy.com/shop/marymariiart

The Screaming Parrots Cafe Set to Ruffle Feathers in Redmond with an Unforgettable Menu Sure to Cause a Fuss

Redmond residents can now get ready for an explosion of flavor and fun as The Screaming Parrots Cafe prepares to land in Redmond this summer! Situated conveniently at 16095 Cleveland Street, formerly home to Top Pot Doughnuts, this exciting new cafe promises a fresh and vibrant twist on dining, sure to become a local favorite.

The Screaming Parrots Cafe is not the ordinary eatery. Inspired by two years of culinary creativity tested alongside their lively, vocal parrots, the founders have perfected a menu that’s both playful and delicious. Whether it’s breakfast, lunch, dinner, or late-night snacks, every dish bursts with freshness, originality, and just a bit of joyful chaos.

Guests can savor a distinctive selection including milk teas, fresh sugarcane juice (available in various flavors), sweet and savory crepes, Onigiri rice balls, specialty coffees, yogurt bowls, and much more.

Highlights of the menu include:

– Fluffy, wobbly Japanese souffle pancakes.

– Fully loaded crepes with creative sweet and savory toppings.

– Authentic Onigiri rice balls crafted with premium ingredients.

– Fruity coffees blended with fresh juices like orange, apple, and sugarcane juice.

– Fresh Vietnamese sugarcane juice, cold-pressed and naturally sweet.

– Top-quality Da Hong Pao tea sourced directly from small farmers in China and brewed with a special technique to achieve deeper, richer flavors.

“There won’t be any boring bites,” promises the Screaming Parrots Cafe team. “No plain sips either. Just unforgettable flavors, endless fun, and maybe a bit of friendly squawking.

The Screaming Parrots Cafe is more than just a dessert shop – it’s a full sensory experience built on quality, creativity, and community. Their vibrant parrots, whose enthusiastic screams inspired the cafe’s playful name, have been cheerfully involved in every step of the process.

The Screaming Parrots Cafe will open its doors to the public seven days a week, from 7 AM to 11 PM, beginning summer 2025.

Stay updated on the grand opening and exclusive previews by following their official Instagram: https://www.instagram.com/thescreamingparrots

ABOUT THE SCREAMING PARROTS CAFE

The Screaming Parrots Cafe, coming soon to Redmond, WA, offers unique delicacies including Japanese souffle pancakes, Onigiri rice balls, specialty crepes, authentic Da Hong Pao teas, and much more served fresh and filled with personality.

Follow on Instagram @TheScreamingParrots

Media Contact
Company Name: The Screaming Parrots Cafe
Email: Send Email
City: REDMOND
State: WASHINGTON
Country: United States
Website: https://www.instagram.com/thescreamingparrots

Actionable Security Unveils Attack Surface Snapshot: A Free Digital Health Check Uncovering Hidden Vulnerabilities in Small Businesses’ Internet-Facing Assets Before Cyber Intruders Strike

Actionable Security, founded by industry veteran and cybersecurity expert Frank Marano, has always been driven by a simple mission: to help people every day protect what matters most. Today, we are excited to announce the launch of Attack Surface Snapshot—a free service that takes a fresh look at your external digital presence to identify potential attack vectors before the bad guys do. This service gives small businesses a risk-free opportunity to see if any virtual windows have been left open, inviting unwanted guests.

Attack Surface Snapshot isn’t an elaborate tool—it’s a focused look at your company’s external footprint. By using the same probing techniques that cybercriminals employ, our service checks for open ports, scrutinizes Common Vulnerabilities and Exposures, and gathers vital Open-Source Intelligence. In essence, we do what the hackers do, so you can know exactly where your vulnerabilities lie. This fresh look helps you take control of your digital health with clear, actionable insights, ensuring you’re not unknowingly throwing a cyber party for intruders.

“From day one, I built Actionable Security to help those who need it the most,” said Frank Marano, Founder of Actionable Security. “With Attack Surface Snapshot, we’re taking a big step towards making robust cybersecurity accessible. We’re offering a no-cost way for businesses to get a realistic look at their online defenses.” Frank’s commitment to demystifying cybersecurity continues to challenge the notion that protecting your data must come with a hefty price tag.

Small businesses often juggle limited resources while facing increasingly complex cyber threats. Attack Surface Snapshot is our way of bridging that gap, empowering organizations with the insights they need to shore up weaknesses before an attack occurs—all at no cost. This release not only underscores our commitment to excellence in cybersecurity but also reinforces our promise to give back to the community by ensuring that robust protection isn’t reserved only for the largest enterprises.

For more information about Actionable Security and its services, visit www.actionablesec.com or connect on LinkedIn (https://www.linkedin.com/company/actionable-sec).

About Actionable Security:

Founded by cybersecurity expert Frank Marano (https://www.linkedin.com/in/fmarano/), Actionable Security is a Sparta, New Jersey-based firm dedicated to helping small businesses strengthen their cybersecurity posture. With decades of experience advising organizations on risk mitigation and cyber defense, the company offers expert-driven solutions that prioritize affordability, practicality, and effectiveness.

Media Contact:

Frank Marano

Actionable Security

+1 2018741343

frank@actionablesec.com

Visit us on social media:

Facebook (http://facebook.com/ActionableSec) | X (https://x.com/Actionable_Sec)

Media Contact
Company Name: Actionable Security
Contact Person: Frank Marano
Email: Send Email
Phone: 1 2018741343
City: Sparta
State: New Jersey
Country: United States
Website: www.actionablesec.com